In 2002, Passoni et al. postulated that ALK could be “an ideal tumor antigen” due to its restricted expression in the “immune privileged” nervous system in which antigens were not presented to the immune system (note: this is true under normal conditions when the nervous system is not compromised by diseases such as neurodegenerative diseases) [34]. The gene discussed is ALK; the disease is neoplasm.